Title for MeetingAbstracts
Alphabetical listing of titles
Protecting woman and children from sexual violence and exploitation in conflict.
Protecting women against sexual transmission--a hierarchical approach.
Protecting women and under-fives from blood transfusion transmitted HIV.
Protection against biohazard exposure in pathogenesis studies of human retrovirus infection in the laboratory rabbit.
Protection against feline immunodeficiency virus (FIV) infection by DNA vaccination.
Protection against heterologous, primary HIV isolate infection of chimpanzees with an adenovirus-gp120 combination vaccine regimen.
Protection against HIV-1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR-5 co-receptor defects.
Protection against HIV-2 in vaccinated cynomolgus monkeys.
Protection against human immunodeficiency virus type 1 (HIV-1) by SV40-mediated delivery of genes interfering with HIV-1 tat.
Protection against Inhalation Anthrax-Induced Lethality by a Human Monoclonal Antibody to Protective Antigen in Rabbits and Cynomolgus Monkeys.
Protection against mucosal challenge with SHIV 89.6P in rhesus macaques immunized with VSV-based vaccine vectors expressing HIV-1 env and SIV- gag.
Protection Against Pathogenic SIVmac251 Infection Elicited by Vaccination of Rhesus Macaques with a Replication Competent Ad-recombinant Priming/Subunit Boosting Regimen.
Protection against R5 HIV-1 infection in vitro by prior immunization with Vaccinia Virus.
Protection against SHIV(IIIB) challenge by the "prime/boost" regimen.
Protection against SIVsm in HIV-2 exposed, seronegative macaques but not in macaques exposed i.r. to subinfectious doses of SIVsm.
Protection against the dual risk of unwanted pregnancy and HIV/AIDS in KwaZulu-Natal, South Africa.
Protection against transplacental passage of HIV-1 in a Kenyan cohort is associated with elevated IFN- in the maternal and fetal circulations.
Protection and cytokine production associated with DNA vaccines against tuberculosis.
Protection by a confined live vaccine against simian immunodeficiency virus challenge.
Protection by SIV Vecb7/IL-12/GM-CSF dna prime followed by SIVsmB7 VLP protein boost after a mucosal SIV challenge correlates with specific recognition of Gag peptides.
Protection by SIV VLP DNA Prime/Protein Boost following Mucosal SIV Challenge Is Markedly Enhanced by IL-12/GM-CSF Coadministration.
Protection for macaques against SIVmac challenge using an inactivated whole virus vaccine.
Protection from Gram-Positive Septic Shock by Neutralization of Macrophage Migration Inhibitory Factor (MIF).
Protection from HIV-1 challenge in chimpanzees by immunization with an HIV-1 canarypox virus recombinant.
Protection from pathogenic simian immunodeficiency virus (SIV) infection correlates with the rapid induction of SIV-specific CD8+ T cells and antibodies in rhesus macaques immunized with a live, attenuated SIV vaccine.
Protection from STD, HIV/AIDS, and unintended pregnancy implications: for multiple method use.
Protection from viremia and disease progression in SIVBK28 infected Macaca mulatta, challenged with SIVmac251/32H.
Protection in Vitro among HIV-Exposed Uninfected Individuals.
Protection in vivo with defective retroviruses.
Protection means condom - social marketing programs in Africa.